Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.44 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HRH2 | P25021 | 2/20 | 0.38 |
| ▸ | HRH1 | P35367 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | F10 | P00742 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6600870 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9DPP7L3MBTL3 | |
| SCHEMBL17152616 | 0.94 | DPP4 (0.44) | DPP4DPP8DPP9DPP7L3MBTL3 | |
| SCHEMBL17152548 | 0.88 | DPP4 (0.49) | DPP4DPP8DPP9DPP7L3MBTL3 | |
| SCHEMBL17152212 | 0.87 | DPP4 (0.48) | DPP4DPP8DPP9DPP7KDM4E | |
| SCHEMBL5981311 | 0.85 | L3MBTL3 (0.46) | DPP8L3MBTL3L3MBTL1HRH2HRH1 | |
| SCHEMBL13995145 | 0.85 | DPP4 (0.45) | DPP4DPP8DPP9DPP7HRH2 | |
| SCHEMBL20413342 | 0.85 | DPP4 (0.45) | DPP4DPP8DPP9DPP7HRH2 | |
| Hydrochloric Acid SCHEMBL5891530 | 0.84 | DPP8 (0.48) | DPP8DPP9DPP7L3MBTL3L3MBTL1 | |
| Hydrochloric Acid SCHEMBL5142564 | 0.84 | L3MBTL3 (0.45) | DPP8L3MBTL3L3MBTL1HRH2HRH1 | |
| SCHEMBL17152285 | 0.84 | DPP8 (0.53) | DPP4DPP8DPP9DPP7L3MBTL3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1409479-B1 | 1-GLYCINYL-4-(1-METHYLPIPERIDIN-4-YL)PIPERAZINES AND -PIPERIDINES AS FACTOR XA ANTAGONISTS | LILLY CO ELI (US) | 2008-01-23 | — | — | EP | disclosed |
| US-7265121-B2 | Chemical compounds | ELI LILLY AND COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-20050026928-A1 | Chemical compounds | ELI LILLY AND COMPANY | 2005-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050026928-A1 | Chemical compounds | F2, F12, F11 | DPP4 2323/4885DPP8 3630/4885DPP9 3067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.